MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...
Medication without Harm

World Patient Safety Day 2022 – Medication Without Harm

Medication use around the world has increased in the last few years; a 2019 CDC...
Image - Effectiveness of Artificial Intelligence–Powered Translation Tools in Developing Medical Publications An Assessment of Japanese-to-English Translation

Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation

Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Plain language summaries

3 Interesting Facts about Plain Language Summaries

Did you know these 3 facts about plain language summaries?...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.